Delivery Order SPE2DB20D3101-SPE2DB25FRBT1

Award Date 2/12/25
Potential Completion Date 2/13/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of febuxostat 40 mg tablets, a medication used for the treatment of gout. The delivery order has a ceiling value of $3,060.37 and is a Firm Fixed Price contract. The period of performance runs through December 19, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of febuxostat 40 mg tablets. The contract has a ceiling value of $17,032.46 and a period of performance through August 1, 2024. It is a firm-fixed price delivery order contract, with no set-aside designation. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Febuxostat 40 mg tablets, a generic medication used to treat gout. The delivery order has a firm fixed price of $1,253.33 and a completion date of September 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to...
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of Febuxostat 40 mg tablets, a medication used to treat gout. The contract has a ceiling value of $1,401.63 and runs through June 12, 2024. Amerisourcebergen is a major pharmaceutical distribution company that holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,119.14 firm fixed-price delivery order is for the supply of febuxostat 40 mg tablets, a medication used to treat gout. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Febuxostat 40 mg tablets, with a ceiling value of $2,408.89 and a performance period through May 12, 2023. The contract is an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Febuxostat 40 mg tablets, a medication used to treat gout. The contract has a ceiling value of $8,793.61 and was awarded on July 18, 2022, with a completion date of July 19, 2022. The contract is a firm fixed-price delivery order, and there is no set-aside designation. Amerisourcebergen Drug Corp holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,365.64, is for the delivery of the drug Febuxostat 40 mg Tablet 30s. The contract has a firm fixed price pricing type and an ultimate completion date of February 11, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,563.56, is for the delivery of the medication febuxostat 40 mg tablets. The contract has a final completion date of May 8, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Febuxostat 40 mg tablets. The contract has a firm fixed price of $1,218.40 and a completion date of August 26, 2022. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FRBT1
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Febuxostat 40 mg tablets, a medication used to treat gout. The award has a ceiling value of $1,419.36 and runs through February 13, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/14/25, 10:40 AM